Imaging study of using positron emission tomography for the effect of nootropics (atomoxetine, sertraline, paroxetine, benztropine) on the athletic performance
Not Applicable
- Conditions
- healthy adults
- Registration Number
- JPRN-UMIN000020150
- Lead Sponsor
- ippon Medical School
- Brief Summary
average dopamine transporter occupancy caudate putamen sertraline 25mg 4.8% 6.5% paroxetine 10mg 3.5% 2.9% atomoxetine 40mg 1.3% 1.1% benztropine 0.5mg -4.7% -6.4%
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Male
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
- with past or current history of psychiatric illness - with past or current history of serious medical illness and/or brain organic diseases - subject who is contraindicated for the use of MRI - with past or current history ofsevere liver disease, kidney disease, heart disease, allergy, or severe drug allergy - subject who are judged as not suitable for participation in this study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method